Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lm Funding America (LMFA) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Lm Funding America (LMFA) over the last 12 years, with Q3 2025 value amounting to $292000.0.

  • Lm Funding America's Cash & Equivalents fell 9506.19% to $292000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $292000.0, marking a year-over-year decrease of 9506.19%. This contributed to the annual value of $3.4 million for FY2024, which is 4064.9% up from last year.
  • As of Q3 2025, Lm Funding America's Cash & Equivalents stood at $292000.0, which was down 9506.19% from $354000.0 recorded in Q2 2025.
  • Lm Funding America's Cash & Equivalents' 5-year high stood at $32.6 million during Q4 2021, with a 5-year trough of $145648.0 in Q2 2024.
  • Moreover, its 5-year median value for Cash & Equivalents was $3.4 million (2023), whereas its average is $8.7 million.
  • Per our database at Business Quant, Lm Funding America's Cash & Equivalents soared by 220641.57% in 2021 and then plummeted by 9539.07% in 2023.
  • Lm Funding America's Cash & Equivalents (Quarter) stood at $32.6 million in 2021, then tumbled by 86.98% to $4.2 million in 2022, then crashed by 43.33% to $2.4 million in 2023, then surged by 40.65% to $3.4 million in 2024, then plummeted by 91.36% to $292000.0 in 2025.
  • Its Cash & Equivalents stands at $292000.0 for Q3 2025, versus $354000.0 for Q2 2025 and $1.0 million for Q1 2025.